Zymergen IPO Securities Settlement
No proof required
Zymergen, its executives, and its underwriter banks issued false and misleading statements regarding the commercial potential of its optical film product pipeline prior to its initial public offering. Eligible investors who purchased or acquired shares under the offering documents and submit a valid claim form will receive a cash distribution.
Payout amount
Amount TBD
Deadline to claim
Expired
Eligibility
You may qualify if: • You must have purchased or otherwise acquired Zymergen Inc. common stock. • Your acquisition of stock must be pursuant and/or traceable to the registration statement and prospectus issued for the company's April 2021 initial public offering.
